The impact of chronic heart failure and comorbidity on the quality of life of patients
DOI:
https://doi.org/10.21638/spbu11.2024.302Abstract
Comorbidity in patients with chronic heart failure has a great influence on the progression and outcomes of other diseases due to the wide involvement of the cardiovascular system in the functioning of other organs and systems of the body. However, numerical assessment of such influence
is difficult due to the high degree of individuality of combinations and progression of pathologies and the complexity of intersystem relationships in patients with comorbidity. In the context of this study, we propose to evaluate the influence of comorbidity in patients with coronary heart disease and chronic heart failure on individual components of quality of life. Comparison of integrated quality of life and comorbidity indexes in patients with different disease combinations and different age groups showed the expected relationships between these indices and identified the quality of life elements most affected by comorbidity. More than other components there was a decline in role emotional and physical functioning. The highest rates of decline with age were
observed in the transition from middle-aged to elderly patients. Health-related quality of life and the Charlson comorbidity index reflect, subjective and objective aspects of the patient’s health, which allows their simultaneous use in the examination of patients with cardiological diseases.
Keywords:
сomorbidity, chronic heart failure, Charlson comorbidity index, SF-36, cardiovascular pathology
Downloads
References
Литература
Лазебник Л. Б., Верткин А. Л., Конев Ю. В. Старение: про-фессиональный врачебный подход(Национальное руководство). М.: Эксмо, 2014. 320 с.
Мамедов М. Н., Бадейникова К. К., Каримов А. К. Мишени для профилактики коморбидности сердечно-сосудистых и онкологических заболе-ваний // Российский кардиологический журнал.2022. Т. 27, № 11. С 115–120.
Комиссарова С. М., Захарова Е. Ю., Севрук Т. В., Устинова И. Б., Красько О. В. Прогностическое значение глобальной продольной деформации у пациентов с гипертрофической кардиомиопатией // Российский кардиологический журнал. 2018. № 2. С. 7–12.
Komajda M., Cosentino F., Ferrari R., Kerneis M., Kosmachova E., Laroche C., Maggioni A. P., Rittger H.,Steg P. G., Szwed H., Tavazzi L., Valgimigli M., Gale C. P. Profile and treatment of chronic coronary syndromes in European Society of Cardi-ology member countries: The ESC EORP CICD–LT registry// Eur. J. Prev. Cardiol. 2021. Vol. 28, no. 4. P. 432–445.
van Manen J. G., Korevaar J. C., Dekker F. W., Boeschoten E. W., Bossuyt P. M., Krediet R. T. How to adjust for comorbidity in survival studies in ESRD patients: A comparison of different indices // American Journal of Kidney Diseases. 2002. Vol. 40, no. 1. P. 82–96.
Hemmelgarn B. R., Manns B. J., Quan H., Ghali W. A. Adapt-ing the Charlson comorbidity index for use in patients with ESRD // American Journal of Kidney Diseases. 2003. Vol. 42, no. 1. Suppl. 2. С. 125–132.
Блохин А. А., Шишкин А. Н., Минкин С. Р. Методы оценки коморбидности и ее роль у пациентов с кардиологической патологией // Вестник Санкт-Петербургского университета. Медицина. 2023. Т. 18, вып. 2. С. 94–111.
Нагибина Ю. В., Захарова Л. А. Качество жизни, медико-социальные характеристики больных ишемической болезнью сердца // Российский кардиологический журнал. 2017. № 3. С. 155–159.
Velarde-Jurado E., Avila-Figueroa C. Methods for quality of life as-sessment // Salud Publica Mex. Instituto Nacional de Salud Publica. 2002. Vol. 44, no. 4. P. 349–361.
Maggino F. Encyclopedia of Quality of Life and Well-Being Re-search. Cham: Springer International Publishing, 2023. P. 7923.
Новик А. А., Ионова Т. И. Руководство по исследованию качества жизни в медицине. М.: ОЛМА Медиа Групп, 2007. 320 с.
Haacke C., Althaus A., Spottke A., Siebert U., Back T., Dodel R. Long-term outcome after stroke: evaluating health-related quality of life using util-ity measurements // Stroke. 2006. Vol. 37, no. 1. P. 193–198.
Кузьмичева О. В. Особенности качества жизни больных ката-рактой и глаукомой до и после хирургического лечения: дис. … канд. мед. наук. СПб.: [б. и.], 2011. 165 с.
Kuan V., Denaxas S., Patalay P., Nitsch D., Mathur R., Gonzalez-Izquierdo A., Sofat R., Partridge L.,Roberts A., Wong I. C. K., Hingorani M., Chaturvedi N., Hemingway H., Hingorani A.D. Identifying and visualising multimorbidity and comorbidity patterns in patients in the English National Health Service: a population-based study // Lancet Digit. Health. 2023. Vol. 5, no. 1. P. 16–27.
Stewart A. L., Hays R. D., Ware J. E. The MOS short-form gen-eral health survey. Reliability and validity in a patient population // Med. Care. 1988. Vol. 26, no. 7. P. 724–735.
Амирджанова В. Н., Горячев Д. В., Коршунов Н. И., Ребров А. П., Сороцкая В. Н. Популяционные показатели качества жизни по опроснику SF-36 (результаты многоцентрового исследования качества жизни «МИРАЖ») // Научно-практическая ревматология. 2008. Т. 46, № 1. С. 36–48.
Deyo R. A., Cherkin D. C., Ciol M. A. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases // J. Clin. Epidemiol. 1992. Vol. 45, no. 6. P. 613–619.
References
Lazebnik L. B., Vertkin A. L., Konev Yu. V. Aging: Professional medi-cal approach (National Guide).Moscow, Eksmo Publ., 2014, 320 p. (In Rus-sian)
Mamedov M. N., Badeinikova K. K., Karimov A. K. Targets for the preven-tion of comorbidity of cardiovascular and cancer diseases.Rossiiskii kardiolog-icheskii zhurnal, 2022, vol. 27, no. 11, pp. 115–120.(In Russian)
Komissarova S. M., Zakharova E. Yu., Sevruk T. V., Ustinova I. B., Krasko O. V. Predictive value of the global longitudinal strain in hypertrophic cardiomyopathy pa-tients. Rossiiskii kardiologicheskii zhurnal, 2018, no. 2, pp. 7–12. (In Rus-sian)
Komajda M., Cosentino F., Ferrari R., Kerneis M., Kosmachova E., Laroche C., Maggioni A. P., Rittger H., Steg P. G., Szwed H., Tavazzi L., Valgimigli M., Gale C. P. Pro-file and treatment of chronic coronary syndromes in European Society of Cardiology mem-ber countries: The ESC EORP CICD-LT registry. Eur. J. Prev. Cardiology, 2021, vol. 28, no. 4, pp. 432–445.
van Manen J. G., Korevaar J. C., Dekker F. W., Boeschoten E. W., Bossuyt P. M., Krediet R. T. How to adjust for comorbidity in survival studies in ESRD patients: A comparison of different indices. AmericanJournal of Kidney Diseases, 2002, vol. 40, no. 1, pp. 82–96.
Hemmelgarn B. R., Manns B. J., Quan H., Ghali W. A. Adapting the Charl-son comorbidity index for use in patients with ESRD. American Journal of Kidney Dis-eases, 2003, no. 1 (42), Suppl. 2, pp. 125–132.
Blokhin A. A., Shishkin A. N., Minkin S. R. Methods for assessing comor-bidity and its role in patients with cardiac pathology. Vestnik of Saint Petersburg Uni-versity. Medicine, 2023, no. 18, issue 2, pp. 94–111. (In Russian)
Nagibina Yu. V., Zakharova L. A. Life quality, medical and social charac-teristics of coronary heart disease patients. Rossiiskii kardiologicheskii zhur-nal, 2017, no. 3, pp. 155–159. (In Russian)
Velarde-Jurado E., Avila-Figueroa C. Methods for quality of life assess-ment. Salud Publica Mex. Instituto Nacional de Salud Publica, 2002, vol. 44, no. 4, pp. 349–361.
Maggino F. Encyclopedia of Quality of Life and Well-Being Re-search. Cham, Springer International Publishing, 2023, 7923 p.
Novik A. A., Ionova T. I. Handbook of quality of life research in medicine. Moscow, OLMA Media Grupp Publ., 2007, 320 p. (In Russian)
Haacke C., Althaus A., Spottke A., Siebert U., Back T., Dodel R. Long-term outcome after stroke: evaluating health-related quality of life using utility measure-ments. Stroke, 2006, vol. 37, no. 1, pp. 193–198.
Kuzmicheva O. V. Features of the quality of life of patients with cataracts and glaucoma before and after surgical treatment: PhD thesis (Medicine). St. Petersburg, [s. n.], 2011, 165 p. (In Russian)
Kuan V., Denaxas S., Patalay P., Nitsch D., Mathur R., Gonzalez-Izquierdo A., Sofat R., Partridge L.,Roberts A., Wong I. C. K., Hingorani M., Chaturvedi N., Hemingway H., Hingorani A. D. Identifying and visualising multimorbidity and comorbidity patterns in patients in the English National Health Service: a population-based study. Lancet Digit. Health, 2023, vol. 5, no. 1, pp. 16–27.
Stewart A. L., Hays R. D., Ware J. E. The MOS short-form general health survey. Reliability and validity in a patient population. Med. Care, 1988, vol. 26, no. 7, pp. 724–735.
Amirdjanova V. N., Goryachev D. V., Korshunov N. I., Rebrov A. P., So-roczkaya V. N. SF-36 question-naire population quality of life indices Objective. Nauchno-prakticheskaia revmatologiia, 2008, vol. 46,no. 1, pp. 36–48. (In Russian)
Deyo R. A., Cherkin D. C., Ciol M. A. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.J. Clinical Epidemiology, 1992, vol. 45, no. 6, pp. 613–619.
Downloads
Published
2025-01-22
How to Cite
Blokhin , A., & Shishkin , A. (2025). The impact of chronic heart failure and comorbidity on the quality of life of patients. Vestnik of Saint Petersburg University. Medicine, 19(3), 205–217. https://doi.org/10.21638/spbu11.2024.302
Issue
Section
Internal medicine
License
Articles of "Vestnik of Saint Petersburg University. Medicine" are open access distributed under the terms of the License Agreement with Saint Petersburg State University, which permits to the authors unrestricted distribution and self-archiving free of charge.
